US3630957A - Diagnostic agent - Google Patents

Diagnostic agent Download PDF

Info

Publication number
US3630957A
US3630957A US683129A US3630957DA US3630957A US 3630957 A US3630957 A US 3630957A US 683129 A US683129 A US 683129A US 3630957D A US3630957D A US 3630957DA US 3630957 A US3630957 A US 3630957A
Authority
US
United States
Prior art keywords
film
diagnostic agent
water
polyvinyl
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US683129A
Inventor
Hans-Georg Rey
Pieter Rieckmann
Hans Wielinger
Walter Rittersdorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of US3630957A publication Critical patent/US3630957A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521Single-layer analytical elements
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/805Test papers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/146666Bile pigment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/171538Urea or blood urea nitrogen
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/17Nitrogen containing
    • Y10T436/173076Nitrite or nitrate

Definitions

  • the present invention relates to a new and improved diagnostic agent for use in the detection of chemical and biochemical components in biological fluids, and more particularly relates to test strips for use in the detection of chemical and biochemical components of biological fluids, a process of preparing such test strips and methods for using the same.
  • test papers with a semi-permeable film and/or membrane or to hydrophobe impregnated and dried papers.
  • these test papers can only be produced by multiple impregnations of filter papers which not only results in technical difliculties from the point of view of production, but also increases their cost considerably. Further, as with an increasing number of process steps, the possible number of production errors increases; either the reliability of the resultant test paper is reduced or additional intermediate controls are necessary, which are of course in and of themselves expensive.
  • a new and improved diagnostic agent i.e., test strip for use in detecting chemical and biochemical components present, for example, in biological fluids such as blood, urine, etc. and other fluids such as milk, etc.
  • a further object of the invention is to provide a new and improved diagnostic agent for use in detecting chemical and biochemical components present in biological fluids characterized by the extreme case with which they are produced and used, as well as by their reliability, i.e., accuracy and reproducibility of results.
  • Still another object of this invention is to provide a new and improved diagnostic agent for safely and reliably detecting single or multiple chemical and biochemical components in biological fluids.
  • diagnostic agents for the detection of biochemical and chemical components in biological fluids which are outstandingly useful and reliable and can be prepared in an economically feasible manner, are obtained by introducing the specific reagents and/or indicators necessary for a detection reaction into a solution or dispersion of the film-forming materials, i.e., the materials required for making the water-resistant films.
  • the film-forming mixture is applied either to a non-retaining substrate or to a substrate to which the film adheres firmly, and the coated or layered substrate is then dried.
  • the film can subsequently be removed, as for example by stripping, from the substrate, whereas in the second case, the substrate serves as a carrier for the film so that in this instance the film itself may be mechanically less stable and thinner.
  • the diagnostic agents according to the present invention for use in the detection of chemical or biochemical components in biological fluids comprises a waterresistant film in which the reagents for the detection reaction are substantially uniformly distributed, the film possibly being supported on a substrate.
  • film-forming agents there can be used those materials which are soluble in organic solvents or which can be dispersed in water, such as cellulose ethers, cellulose esters, cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide, polyamides and other film-forming, natural or synthetic polymers, as well as mixtures thereof.
  • cellulose ethers cellulose esters, cellulose acetate phthalate
  • polyvinyl esters polyvinyl acetals
  • polyacrylic esters polyacrylamide
  • polyamides polyamides and other film-forming, natural or synthetic polymers, as well as mixtures thereof.
  • Ethyl cellulose, acetyl cellulose, polyvinyl acetate, polyvinyl propionate, polyvinyl butyracetal and latex have proved to be especially useful.
  • synthetic resin foils As carriers or supports (substrates) for coating with the films, it is preferred to use synthetic resin foils but it is also possible to use, for example, glass, wood, paper, metal foils and other like materials.
  • the film-forming compositions can also contain any of the conventional fillers and adjuvants, such as for example chalk, titanium dioxide, silica gel, starch, talc, pearl white, metal soaps, cellulose powder and the like, as well as suitable thickening agents, emulsifiers, dispersion agents, plasticizers and the like. Pigments can also be included in the films and serve to render the same opaque.
  • the resultant films can be applied to a colored carrier material; in this manner, the reagent foils, in contradistinction to completely transparent foils, can be compared directly with color charts without porcelain tiles or the like being necessary.
  • composition of the reagents is, in principle, the same as in the case of the previously known diagnostic agents.
  • the presence of glucose can be detected with the use of a mixture of glucose oxidase, peroxidase, buffer and color-forming agent; for the detection of blood in urine, there can be used a mixture of peroxide and a color-forming agent and urobilinogen can be detected with p-dialkylamino-benzaldehyde and a strong acid.
  • test papers and indicator foils consist of the same material, namely, cellulose. Since the synthetic resin films according to the present invention can be made from the most varied materials, the most compatible and best suited material for each special purpose can be selected.
  • the materials used according to the present invention can be worked up much more easily with constant quality, are more homogeneous; and consequently are more dependable. Furthermore, We have found that not only the mechanical stability of the foils, but in addition the stability of the reagents is better than in the case of test papers. Even after the reaction has taken place with the body fluid being analyzed, the new test foils according to the present invention are considerably more stable than the previously used test papers so that the results obtained can, if desired, be evaluated at a later time or can even be checked after several days.
  • diagnostic agents according to the present invention for the detection of glucose in blood or urine can be enclosed with a patients examination report and can be filed away with the records relating to the findings in the patients file history.
  • the production of the new diagnostic agents according to the present invention takes place, in the simplest way, by the application of the film-forming solution or dispersion to a suitable substrate, followed by drying.
  • the film-forming solution or dispersion to a suitable substrate, followed by drying.
  • the resultant foil is cut at right angles to the direction of application, to thereby provide narrow strips suitable for simultaneously detecting a variety of components, i.e., there are obtained multi-test strips.
  • the synthetic resin films according to the present invention can be produced having any desired thickness and with any desired reagent concentration. Since the reagents also cannot be leached out or non-uniformly distributed by chromatographic effects, the fluid to be investigated can, if desired, be left to act upon the film for a comparatively long period of time, a stronger color reaction thereby being produced. Therefore, the new diagnostic agents according to the present invention can be used not only for the previously known test reactions but also for those which, because of the known disadvantages of test papers, have hitherto not been capable of being made up into the considerably simpler and easier used form of a test strip.
  • EXAMPLE 1 A reagent film for the detection of glucose in, for example, urine or whole blood, was prepared as follows: A mixture having the following composition was first prepared:
  • EXAMPLE 2 For the production of a reagent foil for use in the detection of glucose in, for example, urine or whole blood, there was first prepared a mixture having the following composition:
  • a 500a thick layer of the above mixture was applied onto a white polyvinyl chloride foil and the foil thereafter dried with warm air. There was obtained a water-insoluble film, the properties of which corresponded to those of the film described in Example 1.
  • a diagnostic agent for use in the detection of blood in urine was prepared as follows: A mixture having the following composition was prepared:
  • the above mixture was applied onto a polyvinyl chloride foil so as to provide a 500; thick layer and the thusly treated foil is then dried with warm air. There was obtained a water-insoluble film which, upon being immersed into blood-containing urine, provided a more or less strong color, corresponding to the concentration of blood in the urine specimen.
  • the mixture was then applied to a polyvinyl chloride foil so as to produce a 300,11. thick layer and the layered foil was then dried with warm air. There was obtained a water-insoluble film which, on being moistened with urobilinogen-containing urine, evidenced a more or less dark red color, depending upon the urobilinogen con centration.
  • EXAMPLE 6 For the production of a regagent film for use in the detection of glucose in, for example, urine or whole blood, there was first prepared a mixture having the following composition:
  • the mixture was then applied to a white polyvinyl chloride foil so as to provide a 300 thick layer of the mixture, and the thusly layered foil dried with warm air. There was obtained a water-insoluble film which on reaction with glucose, for example, in blood in a concentration within the range of 50-250 mg. percent evidenced a strong color.
  • EXAMPLE 7 90 g. of an aqueous dispersion of polyvinyl propionate (Propiofan), 1.3 g. of the sodium salt of a polymannuronic acid (Algipon), 70 ml. of a 0.5 M citrate or phosphate buffer having a pH value of 5.5, 2 g. of organic sodium sulfonate (Texapon P), 320 mg. glucose oxidase, 300 mg. peroxidase and 300 mg. 1-methoxy-4-hydroxynaphthalene in 20 ml. methanol were stirred together to form a homogeneous mixture. This mixture was then applied onto a foil to provide a layer thereof having a thickness of 300 2 and the layered foil dried.
  • Algipon polymannuronic acid
  • Texapon P organic sodium sulfonate
  • Propiofan, Algipon, and Texapon P are trademarks of BASF, Henkel and Dehydag respectively.
  • EXAMPLE 8 g. of polyvinyl propionate dispersion (Propiofan), 35 g. of a 1.85% solution of polymannuronic acid (Algipon) in 0.5 M phosphate buffer having a pH value of 5.5, 1 g. of organic sodium sulfonate (Texapon), 0.075 g. peroxidase, 0.15 g. glucose oxidase, 0.045 g. 3-amino-9-ethyl-carbazole and 0.25 g. o-tolidine dissolved in 6 ml. methanol, were stirred to form a homogeneous slurry. 0.50 ml.
  • a diagnostic agent for use in the detection of chemical and bio-chemical components in biological fluids comprising a homogeneous water-resistant film formed from a mixture of an aqueous dispersion of a natural or synthetic organic polymer and a color forming reagent capable of producing color in response to the presence of a chemical or bio-chemical component in a biological fluid, in which said color forming reagent is uniformly dispersed throughout the film.
  • a diagnostic agent according to claim 1 including a carrier support for said film.
  • a diagnostic agent according to claim 2 wherein said film is firmly attached to said carrier support to form an integral structure therewith.
  • a diagnostic agent according to claim 2 wherein said carrier support is a member selected from the group consisting of glass, paper, asbestos, wood, metal and synthetic resins inert to the biological fluid.
  • a diagnostic agent according to claim 1 wherein said water-resistant film is prepared on a basis of at least one polymer selected from the group consisting of polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamides and polyamides.
  • a diagnostic agent according to claim 1 wherein said water-resistant film is prepared on a basis of at least one member selected from the group consisting of cellulose ethers and cellulose esters.
  • a diagnostic agent according to claim 6 wherein the said member is polyvinyl acetate, polyvinyl propionate or polyvinyl butyracetal.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyvinyl propionate dispersion100.00 g. o-Vanillin-(vanilloyl)-hydrazone2.50 g. Glucose oxidase0.06 g.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises Ethyl cellulose-35.00 g. o-Vanillin-(vanilloyl) -hydrazone1.7 g. Glucose oxidase0.04 g.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises o-Tolidine-0.25 g.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises p-Dimethylamino-benzaldehyde-l .0 g. Orthophosphoric acid )20.0 g. Polyvinyl acetal20.0 g.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises a-Naphthylamine1.0 g. Sulfanilamide-2.5 g. Trichloroacetic acid3.0 g. Polyvinyl butyracetal20.0 g. Methanol-100.0 ml.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyvinyl propionate dispersion45 .0 g. Phosphate buffer 0.4 M (pH 5.5)45.0 ml. Sodium alginate0.5 g.
  • said water-resistant film comprises g. of an aqueous dispersion of polyvinyl propionate, 1.3 g. of the sodium salt of a polymannuronic acid, 70 ml. of a 0.5 M citrate or phosphate buffer having a pH value of 5.5, 2 g. of organic sodium sulfonate, 320 mg. glucose oxidase, 300 mg. peroxidase and 300 mg. 1-methoxy-4-hydroxy-naphthalene in 20 ml. methanol, in dried form.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises 45 g. of a polyvinyl propionate dispersion, 35 g. of a 1.85% solution of polymannuronic acid in 0.5 M phosphate buffer having a pH value of 5.5, 1 g. of organic sodium sulfonate, 0.075 g. peroxidase, 0.15 g. glucose oxidase, 0.045 g. 3-amino-9- ethyl-carbazole and 0.25 g. o-tolidine dissolved in 6 ml. methanol, in dried form.
  • a diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyisobutylene dispersion 22.50 Sodium alginate solution (1.85%) in 0.15 M
  • Method of detecting a chemical or biochemical component in a biological fluid which comprises contacting a diagnostic agent according to claim 1 with said fluid and comparing the color of said diagnostic agent with a standard.
  • a diagnostic agent for use in the detection of chemical and bio-chemical components in biological fluids comprising a homogeneous water-resistant film formed from a mixture of an aqueous dispersion of a natural or synthetic organic polymer selected from the group consistiing of cellulose ethers, cellulose esters cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide and polyamides, and a color forming reagent capable of producing color in response to the presence of a chemical or bio-chemical component in a biological fluid, in which the color forming reagent is uniformly dispersed throughout the film.
  • a natural or synthetic organic polymer selected from the group consistiing of cellulose ethers, cellulose esters cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide and polyamides, and a color forming reagent capable of producing color in response to the presence of a chemical or bio

Abstract

DIAGNOSTIC AGENTS FOR USE IN THE DETECTION OF BIOCHEMICAL AND CHEMICAL COMPONENTS IN BLOOD, URINE AND OTHER BIOLOGICAL FLUIDS ARE DISCLOSED COMPRISING WATER-RESISTANT FILMS IN WHICH A COMPOSITION FORMING COLOR IN RESPONSE TO SAID CHEMICAL OR BIOLOGICAL COMPONET IS UNIFORMLY DISTRIBUTED.

Description

United States Patent US. Cl. 252-408 24 Claims ABSTRACT OF THE DISCLOSURE Diagnostic agents for use in the detection of biochemical and chemical components in blood, urine and other biological fluids are disclosed comprising water-resistant films in which a composition forming color in response to said chemical or biological component is uniformly distributed.
The present invention relates to a new and improved diagnostic agent for use in the detection of chemical and biochemical components in biological fluids, and more particularly relates to test strips for use in the detection of chemical and biochemical components of biological fluids, a process of preparing such test strips and methods for using the same.
The detection of chemical and biochemical components in biological fluids is of ever increasing importance in connection with medical diagnosis and treatment. The detection, i.e. analytical procedures, have already been considerably simplified by the provision of test tablets and test papers. Unfortunately the diagnostic agents of this type leave a lot to be desired with regard to their actual use, as well as with regard to their reliability. Furthermore, the large scale production thereof frequently gives rise to dilficulties. This is particularly true as concerns the diagnostic agents provided for use in the determination of chemical and biochemical components in cloudy and strongly colored liquids, such as whole blood.
It has already been proposed to coat conventional test papers with a semi-permeable film and/or membrane or to hydrophobe impregnated and dried papers. However, these test papers can only be produced by multiple impregnations of filter papers which not only results in technical difliculties from the point of view of production, but also increases their cost considerably. Further, as with an increasing number of process steps, the possible number of production errors increases; either the reliability of the resultant test paper is reduced or additional intermediate controls are necessary, which are of course in and of themselves expensive.
In connection with the determination of the hydrogen ion concentration required to be carried out in cloudy, muddy or strongly colored liquids and fluids, it has already been proposed to use cellulose foils containing indicators (c.f. P. Wullf, Kolloid Z., 40, 341/1926). These cellulose foils constitute however highly swellable, hydrophilic and non-water-resistant membranes which, in addition, are diflicult to produce from a technical point of view. Thus, in the production of such pH test foils, the indicator-containing cellulose solutions must be forced through slits into an acid bath and must subsequently be subjected to a further treatment until there are no longer any acid residues in the foil.
It is an object of the invention to provide a new and improved diagnostic agent, i.e., test strip for use in detecting chemical and biochemical components present, for example, in biological fluids such as blood, urine, etc. and other fluids such as milk, etc.
A further object of the invention is to provide a new and improved diagnostic agent for use in detecting chemical and biochemical components present in biological fluids characterized by the extreme case with which they are produced and used, as well as by their reliability, i.e., accuracy and reproducibility of results.
Still another object of this invention is to provide a new and improved diagnostic agent for safely and reliably detecting single or multiple chemical and biochemical components in biological fluids.
These and other objects and advantages will be apparent from a consideration of the following disclosure.
In accordance with the invention, it has now been found that diagnostic agents for the detection of biochemical and chemical components in biological fluids, which are outstandingly useful and reliable and can be prepared in an economically feasible manner, are obtained by introducing the specific reagents and/or indicators necessary for a detection reaction into a solution or dispersion of the film-forming materials, i.e., the materials required for making the water-resistant films. For this purpose, the film-forming mixture is applied either to a non-retaining substrate or to a substrate to which the film adheres firmly, and the coated or layered substrate is then dried. In the first case, the film can subsequently be removed, as for example by stripping, from the substrate, whereas in the second case, the substrate serves as a carrier for the film so that in this instance the film itself may be mechanically less stable and thinner.
Thus, the diagnostic agents according to the present invention for use in the detection of chemical or biochemical components in biological fluids comprises a waterresistant film in which the reagents for the detection reaction are substantially uniformly distributed, the film possibly being supported on a substrate.
As film-forming agents there can be used those materials which are soluble in organic solvents or which can be dispersed in water, such as cellulose ethers, cellulose esters, cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide, polyamides and other film-forming, natural or synthetic polymers, as well as mixtures thereof. Ethyl cellulose, acetyl cellulose, polyvinyl acetate, polyvinyl propionate, polyvinyl butyracetal and latex have proved to be especially useful.
As carriers or supports (substrates) for coating with the films, it is preferred to use synthetic resin foils but it is also possible to use, for example, glass, wood, paper, metal foils and other like materials.
In addition to the reagents which are required for the detection reaction, the film-forming compositions can also contain any of the conventional fillers and adjuvants, such as for example chalk, titanium dioxide, silica gel, starch, talc, pearl white, metal soaps, cellulose powder and the like, as well as suitable thickening agents, emulsifiers, dispersion agents, plasticizers and the like. Pigments can also be included in the films and serve to render the same opaque. The resultant films can be applied to a colored carrier material; in this manner, the reagent foils, in contradistinction to completely transparent foils, can be compared directly with color charts without porcelain tiles or the like being necessary.
The addition of small amounts of wetting agents to the film-forming solutions or dispersions has the effect that the resultant solutions or dispersions can be more uniformly coated onto the hydrophobic synthetic resin foils without the other properties of the diagnostic agents according to the present invention being thereby substantially changed.
The composition of the reagents, as required for the detection of the biochemical and chemical components in body fluids, is, in principle, the same as in the case of the previously known diagnostic agents. Thus, for example, the presence of glucose can be detected with the use of a mixture of glucose oxidase, peroxidase, buffer and color-forming agent; for the detection of blood in urine, there can be used a mixture of peroxide and a color-forming agent and urobilinogen can be detected with p-dialkylamino-benzaldehyde and a strong acid. As examples of other typical clinical tests which are of importance in the analysis of blood and other body fluids, there may be mentioned the Griess nitrite test, the detection of uric acid with the help of uricase-peroxidase and a color-forming agent, the detection of galactose, phosphatases, chlorinesterase, urea, etc.
It was certainly not to have been foreseen that the new diagnostic agents according to the present invention could even be used for the intended purpose since it was to have been assumed that the reagents incorporated as herein water-resistant and, in general, hydrophobic films, would either not react at all with the fluid to be investigated, or would not react quickly enough. Typical hydrophilic and non-water-resistant foils, such as those of cellulose or gelatine, swell in water and are able to take up several times their own weight of water. Nevertheless, in the case of cellulose indicator foils, the take-up of water in comparison with the absorbency of paper is already reduced to such an extent that the Wultf indicator foils must-be dipped in the fluid under investigation for at least one minute. In the case of the determination of pH, using therefor cellulose reagent foils, it only depends upon the migration velocity of the mobile and small hydrogen and hydroxyl ions, whereas in the case of the diagnostic agents according to the present invention, the substantially larger and considerably less mobile molecules of the components to be detected in body fluids must pass through the film material in order to reach the reagents.
It is also surprising that such large and sensitive molecules as those of enzymes also retain their reactivity in the solid solutions of the synthetic resin films. In addition, it is extremely surprising that, in spite of the improved protection of the reagents from external influences, enzyme reactions requiring oxygen, as for example the detection of glucose by means of glucose oxidase, peroxidase and a color forming agent, also take place quickly and without trouble in the diagnostic agents according to the present invention.
The advantage of the new diagnostic agents according to the present invention, in comparison with the previously known test papers and indicator foils, lies in particular in their greatly simplified production. In comparison with the cellulose foils, there is the further advantage that precipitation in an acid bath is not necessary, in connection with which sensitive reagents are destroyed or decomposed. From the chemical point of view, test papers and cellulose foils consist of the same material, namely, cellulose. Since the synthetic resin films according to the present invention can be made from the most varied materials, the most compatible and best suited material for each special purpose can be selected.
Furthermore, the materials used according to the present invention can be worked up much more easily with constant quality, are more homogeneous; and consequently are more dependable. Furthermore, We have found that not only the mechanical stability of the foils, but in addition the stability of the reagents is better than in the case of test papers. Even after the reaction has taken place with the body fluid being analyzed, the new test foils according to the present invention are considerably more stable than the previously used test papers so that the results obtained can, if desired, be evaluated at a later time or can even be checked after several days. Thus, for example, diagnostic agents according to the present invention for the detection of glucose in blood or urine, can be enclosed with a patients examination report and can be filed away with the records relating to the findings in the patients file history.
The production of the new diagnostic agents according to the present invention takes place, in the simplest way, by the application of the film-forming solution or dispersion to a suitable substrate, followed by drying. In the case of the continuous application of narrow film strips onto adhering synthetic resin foils, it is, in addition, possible to apply different reagent mixtures side by side onto a foil. After the drying has been completed, the resultant foil is cut at right angles to the direction of application, to thereby provide narrow strips suitable for simultaneously detecting a variety of components, i.e., there are obtained multi-test strips.
In contradistinction to test papers, the reagent concentration of which cannot be varied as desired because of the absorbency and the saturation limit of the paper, the synthetic resin films according to the present invention can be produced having any desired thickness and with any desired reagent concentration. Since the reagents also cannot be leached out or non-uniformly distributed by chromatographic effects, the fluid to be investigated can, if desired, be left to act upon the film for a comparatively long period of time, a stronger color reaction thereby being produced. Therefore, the new diagnostic agents according to the present invention can be used not only for the previously known test reactions but also for those which, because of the known disadvantages of test papers, have hitherto not been capable of being made up into the considerably simpler and easier used form of a test strip.
The following examples are given for the purpose of illustrating the present invention and are not to be construed as a limitation thereof:
EXAMPLE 1 A reagent film for the detection of glucose in, for example, urine or whole blood, was prepared as follows: A mixture having the following composition was first prepared:
Polyvinyl propionate dispersionl00.00 g.
o-Vanillin- (vanilloyl -hydrazone2.50 g.
Glucose oxidase-0.06 g.
Peroxidasc0.01 g.
Colloidal silicic acid4.00 g.
Phosphte buffer 0.4 M (pH 5.7)70.00 ml.
Sodium alignate solution (2.5% )-35.00 g.
Organic sodium sulfonate (Rapidnetzer BASF)1.6 g. Methanol-40.00 ml.
There was applied a 400a thick layer of the above mixture onto a white polyvinyl chloride foil and the foil then dried with warm air. There was thusly formed a water-insoluble film which provides graduated violet colors on reaction with glucose in, for example, urine or blood. The reaction with glucose in blood can be seen as soon as the blood is wiped or washed olf the foil. The colors produced in the reactions are very easily seen against the background of the white carrier foil.
EXAMPLE 2 For the production of a reagent foil for use in the detection of glucose in, for example, urine or whole blood, there was first prepared a mixture having the following composition:
Ethyl cellulose-35.00 g.
o-Vanillin- (vanilloyl -hydrazonel .7 g.
Glucose oxidase0.04 g.
Peroxidase-0011 g.
Colloidal silicic acid-2.00 g.
Phosphate buffer 0.4 M (pH 5.7)-25.00 ml.
Organic sodium sulfonate-(Rapidnetzer BASF)-- Methanol--75.00 ml.
A 500a thick layer of the above mixture was applied onto a white polyvinyl chloride foil and the foil thereafter dried with warm air. There was obtained a water-insoluble film, the properties of which corresponded to those of the film described in Example 1.
EXAMPLE 3 A diagnostic agent for use in the detection of blood in urine was prepared as follows: A mixture having the following composition was prepared:
o-Tolidine-0.25 g.
Strontium peroxide-2.0 g. Tartaric acid-3.75 g.
Calcium acetate7.0 g. Colloidal silicic acid1.5 g. Sodium carbonate2.0 g. Polyvinyl acetate-5.0 g. Anhydrous isopropanol-70.0 ml.
The above mixture was applied onto a polyvinyl chloride foil so as to provide a 500; thick layer and the thusly treated foil is then dried with warm air. There was obtained a water-insoluble film which, upon being immersed into blood-containing urine, provided a more or less strong color, corresponding to the concentration of blood in the urine specimen.
EXAMPLE 4 In order to provide reagent films for use in the detection of urobilinogen in urine, there was first prepared a mixture having the following composition:
p-Dimethylamino-benzaldehyde-1.0 g.
Orthophosphoric acid (85%)20.0 g.
Polyvinyl acetal-20.0 g.
Organic sodium sulfonate (Rapidnetzer BASF)0.5 g. Methanol-100.0 ml.
The mixture was then applied to a polyvinyl chloride foil so as to produce a 300,11. thick layer and the layered foil was then dried with warm air. There was obtained a water-insoluble film which, on being moistened with urobilinogen-containing urine, evidenced a more or less dark red color, depending upon the urobilinogen con centration.
EXAMPLE 5 Reagent films for use in the detection of nitrite in urine were produced, using a mixture having the following composition:
a-Naphthylamine-1.0 g.
Sulfanilamide2.5 g. Trichloroacetic acid3.0 g. Polyvinyl butyracetal-20.0 g. Methanol100.0 ml.
The above mixture was applied onto a polyvinyl chloride foil to provide a 400 thick layer, and the resultant foil was then dried with warm air. There was obtained a water-insoluble film which, when moistened with nitritecontaining urine, evidenced a more or less dark red color which was directly dependent upon the nitrite content.
EXAMPLE 6 For the production of a regagent film for use in the detection of glucose in, for example, urine or whole blood, there was first prepared a mixture having the following composition:
Polyvinyl propionate dispersion-45.0 g.
Phosphate bufier 0.4 M (pH 5 .5 )45 .0 ml.
Sodium alginate0.5 g.
Organic sodium sulfonate (Rapidnetzer BASF)0.6 g. 3-amino-19-ethyl-carbazole-0.03 g.
oTolidihe0.2 g.
Glucose oxidase-0.04 g.
o-Tolidine0.2 g.
Methanol6.0 g.
The mixture was then applied to a white polyvinyl chloride foil so as to provide a 300 thick layer of the mixture, and the thusly layered foil dried with warm air. There was obtained a water-insoluble film which on reaction with glucose, for example, in blood in a concentration within the range of 50-250 mg. percent evidenced a strong color.
When a drop of blood was placed on the test strip and then again removed after about one minute, depending upon the glucose concentration, the strip evidenced an orange to blue-green color.
EXAMPLE 7 90 g. of an aqueous dispersion of polyvinyl propionate (Propiofan), 1.3 g. of the sodium salt of a polymannuronic acid (Algipon), 70 ml. of a 0.5 M citrate or phosphate buffer having a pH value of 5.5, 2 g. of organic sodium sulfonate (Texapon P), 320 mg. glucose oxidase, 300 mg. peroxidase and 300 mg. 1-methoxy-4-hydroxynaphthalene in 20 ml. methanol were stirred together to form a homogeneous mixture. This mixture was then applied onto a foil to provide a layer thereof having a thickness of 300 2 and the layered foil dried. A drop of blood or serum placed upon a film produced in this manner, which was then removed after about one minute resulted in that the film assumed a blue color, the strength of the color depending upon the concentration of the glucose in the blood sample. Propiofan, Algipon, and Texapon P are trademarks of BASF, Henkel and Dehydag respectively.
EXAMPLE 8 g. of polyvinyl propionate dispersion (Propiofan), 35 g. of a 1.85% solution of polymannuronic acid (Algipon) in 0.5 M phosphate buffer having a pH value of 5.5, 1 g. of organic sodium sulfonate (Texapon), 0.075 g. peroxidase, 0.15 g. glucose oxidase, 0.045 g. 3-amino-9-ethyl-carbazole and 0.25 g. o-tolidine dissolved in 6 ml. methanol, were stirred to form a homogeneous slurry. 0.50 ml. of a 0.5% methanolic solution of Sico-Fettblau 50401 N (Siegle & Co., Stuttgart- Feuerbach) were then added thereto. The mixture so prepared was applied to a synthetic resin foil at a layer thickness of 300a and the layered foil then dried. When there were applied to the thusly produced foils samples of urine having various glucose concentrations and following a short reaction time, the urine wiped off, then in the case of a glucose concentration of mg. percent the film was colored bright pink; at a concentration of 250 mg. percent it was colored dark orange-pink; at a concentration of 500 mg. percent it was colored green, and at a concentration of 1000 mg. percent it was colored dark green. It is thus apparent that a clearly gradulated color change occurred which was directly correlated to the concentration of glucose.
EXAMPLE 9 For the production of a reagent film for use in the detection of urea there was first prepared a mixture having the following composition:
Polyisobutylene dispersion (Oppanol B,
BASF) 22.50 Sodium alginate solution (1.85%) in 0.15 M phosphate bulfer (pH 6.8) 19.50 Urease 0.25 Brilliant Yellow (E. Merck) 0.02 Organic sodium sulfonate (Texapon P) 0.50
wiped off after 45 seconds. There were obtained, depending upon the urea concentration, colors ranging from yellow-orange to orange to red-orange.
We claim:
1. A diagnostic agent for use in the detection of chemical and bio-chemical components in biological fluids comprising a homogeneous water-resistant film formed from a mixture of an aqueous dispersion of a natural or synthetic organic polymer and a color forming reagent capable of producing color in response to the presence of a chemical or bio-chemical component in a biological fluid, in which said color forming reagent is uniformly dispersed throughout the film.
2. A diagnostic agent according to claim 1 including a carrier support for said film.
3. A diagnostic agent according to claim 2 wherein said film is removably attached to said carrier support.
4. A diagnostic agent according to claim 2 wherein said film is firmly attached to said carrier support to form an integral structure therewith.
5. A diagnostic agent according to claim 2 wherein said carrier support is a member selected from the group consisting of glass, paper, asbestos, wood, metal and synthetic resins inert to the biological fluid.
6. A diagnostic agent according to claim 1 wherein said water-resistant film is prepared on a basis of at least one polymer selected from the group consisting of polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamides and polyamides.
7. A diagnostic agent according to claim 1 wherein said water-resistant film is prepared on a basis of at least one member selected from the group consisting of cellulose ethers and cellulose esters.
8. A diagnostic agent according to claim 7 wherein said water-resistant film is based at least partly on ethyl cellulose or acetyl cellulose.
9. A diagnostic agent according to claim 6 wherein the said member is polyvinyl acetate, polyvinyl propionate or polyvinyl butyracetal.
10. A diagnostic agent according to claim 1 wherein said water-resistant film additionally contains at least one member selected from the group consisting of fillers thickening agents, emulsifiers, dispersion agents and plasticizers.
11. A diagnostic agent according to claim 1 wherein said water-resistant film additionally contains a pigment for rendering the same opaque.
12.. A diagnostic agent according to claim 11 wherein said water-resistant film is applied onto a colored carrier support.
13. A diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyvinyl propionate dispersion100.00 g. o-Vanillin-(vanilloyl)-hydrazone2.50 g. Glucose oxidase0.06 g.
Peroxidase0.0l g.
Colloidal silicic acid-4.00 g.
Phosphate buffer 0.4 M (pH 5.7)70.00 ml. Sodium alginate solution (2.5% )35.00 g. Organic sodium sulfonate-1.6 g. Methanol-40.00 ml.
in dried form.
14. A diagnostic agent according to claim 1 wherein said water-resistant film comprises Ethyl cellulose-35.00 g. o-Vanillin-(vanilloyl) -hydrazone1.7 g. Glucose oxidase0.04 g.
Peroxidase0.011 g.
Colloidal silicic acid-2.00 g.
Phosphate buffer 0.4 M (pH 5.7)25.00 ml. Organic sodium sulfonate-LOO g. Methanol75.00 ml.
in dried form.
15. A diagnostic agent according to claim 1 wherein said water-resistant film comprises o-Tolidine-0.25 g.
Strontium peroxide2.0 g. Tartaric acid3.75 g.
Calcium acetate--7.0 g. Colloidal silicic acid-1.5 g. Sodium carbonate-2.0 g. Polyvinyl acetate5.0 g. Anhydrous isopropanol--70.0 ml.
in dried form.
16. A diagnostic agent according to claim 1 wherein said water-resistant film comprises p-Dimethylamino-benzaldehyde-l .0 g. Orthophosphoric acid )20.0 g. Polyvinyl acetal20.0 g.
Organic sodium sulfonate0.5 g. Methanol100.0 ml.
in dried form.
17. A diagnostic agent according to claim 1 wherein said water-resistant film comprises a-Naphthylamine1.0 g. Sulfanilamide-2.5 g. Trichloroacetic acid3.0 g. Polyvinyl butyracetal20.0 g. Methanol-100.0 ml.
in dried form.
18. A diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyvinyl propionate dispersion45 .0 g. Phosphate buffer 0.4 M (pH 5.5)45.0 ml. Sodium alginate0.5 g.
Organic sodium sulfonate0.6 g. 3-amino-9-ethyl-carbazole0.03 g. o-Tolidine-0.2 g.
Glucose oxidase0.04 g.
Peroxidase0.02 g.
Methanol6.0 g.
in dried form.
19. A diagnostic agent according to claim 1 wherein said water-resistant film comprises g. of an aqueous dispersion of polyvinyl propionate, 1.3 g. of the sodium salt of a polymannuronic acid, 70 ml. of a 0.5 M citrate or phosphate buffer having a pH value of 5.5, 2 g. of organic sodium sulfonate, 320 mg. glucose oxidase, 300 mg. peroxidase and 300 mg. 1-methoxy-4-hydroxy-naphthalene in 20 ml. methanol, in dried form.
20. A diagnostic agent according to claim 1 wherein said water-resistant film comprises 45 g. of a polyvinyl propionate dispersion, 35 g. of a 1.85% solution of polymannuronic acid in 0.5 M phosphate buffer having a pH value of 5.5, 1 g. of organic sodium sulfonate, 0.075 g. peroxidase, 0.15 g. glucose oxidase, 0.045 g. 3-amino-9- ethyl-carbazole and 0.25 g. o-tolidine dissolved in 6 ml. methanol, in dried form.
21. A diagnostic agent according to claim 1 wherein said water-resistant film comprises Polyisobutylene dispersion 22.50 Sodium alginate solution (1.85%) in 0.15 M
phosphate buffer (pH 6.8) 19.50
Urease 0.25
Yellow indicator dye 0.02
Organic sodium sulfonate 0.50
in dried form 22. Method of detecting a chemical or biochemical component in a biological fluid, which comprises contacting a diagnostic agent according to claim 1 with said fluid and comparing the color of said diagnostic agent with a standard.
23. A diagnostic agent according to claim 1 wherein the film is based at least in part on latex.
24. A diagnostic agent for use in the detection of chemical and bio-chemical components in biological fluids comprising a homogeneous water-resistant film formed from a mixture of an aqueous dispersion of a natural or synthetic organic polymer selected from the group consistiing of cellulose ethers, cellulose esters cellulose acetate phthalate, polyvinyl esters, polyvinyl acetals, polyacrylic esters, polyacrylamide and polyamides, and a color forming reagent capable of producing color in response to the presence of a chemical or bio-chemical component in a biological fluid, in which the color forming reagent is uniformly dispersed throughout the film.
References Cited UNITED STATES PATENTS JOHN T. GOOLKASIAN, Primary Examiner M. E. MCCAMISH, Assistant Examiner US. Cl. X.R.
UNITED SIA'I'I'JS I'A'I'IL'II'I' ur'r'lus s I CERTIFICATE Oh CORRECTION Patent No. 3,630,957 Dated December 28. 1971 Hans-Georg Rey, Pieter Rieckmann, Hans Wielinger and Walter Rittersdorf Inventor(s) It is eertified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:
C01. 5, line 71 "19" should be -9-- Col. 5 line 72 Delete "o-To1idi.he-O.2 g." and insert O-Tolidine-O.2g. "line 74, "O-To1idine-0.2g.",
should read Peroxidase-0.02g.
Signed and sealed this L .th day of July 1972.
'( SEAL) Attest:
ROBERT GOTTSCHALKe EDWARD M.FLETCHER, JR. Attestlng Officer Commissioner of .Patents
US683129A 1966-11-22 1967-11-15 Diagnostic agent Expired - Lifetime US3630957A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0089944 1966-11-22

Publications (1)

Publication Number Publication Date
US3630957A true US3630957A (en) 1971-12-28

Family

ID=6985034

Family Applications (1)

Application Number Title Priority Date Filing Date
US683129A Expired - Lifetime US3630957A (en) 1966-11-22 1967-11-15 Diagnostic agent

Country Status (12)

Country Link
US (1) US3630957A (en)
JP (1) JPS4933800B1 (en)
AT (1) AT282832B (en)
BR (1) BR6794865D0 (en)
CH (1) CH480634A (en)
CY (1) CY789A (en)
DE (1) DE1598153C3 (en)
FI (1) FI48306C (en)
GB (1) GB1159627A (en)
GR (1) GR38283B (en)
NL (1) NL145048B (en)
SE (1) SE413439B (en)

Cited By (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897214A (en) * 1971-11-24 1975-07-29 Boehringer Mannheim Gmbh Diagnostic device
US3975162A (en) * 1974-03-13 1976-08-17 Marine Colloids, Inc. Applying reagent to medium and device therefor
US4020006A (en) * 1975-08-14 1977-04-26 Icl/Scientific Fluid containing dispersed particles simulating leukocytes and method for producing same
DE2614192A1 (en) * 1976-04-02 1977-10-20 Marine Colloids Inc ANALYZING DEVICE AND ANALYZING METHOD
US4066403A (en) * 1975-06-20 1978-01-03 Eastman Kodak Company Multilayer analytical element
US4175923A (en) * 1978-06-26 1979-11-27 Friend William G Method and apparatus for occult blood testing in the home
USRE30267E (en) * 1975-06-20 1980-05-06 Eastman Kodak Company Multilayer analytical element
US4283491A (en) * 1977-09-06 1981-08-11 Eastman Kodak Company Analytical elements with improved reagent stability
US4298498A (en) * 1978-12-21 1981-11-03 Boehringer Mannheim Gmbh Control reagent for test strips for determining urobilinogen in urine
US4303753A (en) * 1980-03-20 1981-12-01 Miles Laboratories, Inc. Method and device for the semiquantitative determination of glucose in aqueous fluids
US4312834A (en) * 1979-03-15 1982-01-26 Boehringer Mannheim Gmbh Diagnostic agent for the detection of component materials in liquid and process for producing same
US4318985A (en) * 1981-01-29 1982-03-09 Miles Laboratories, Inc. Method and device for detecting glucose concentration
US4388271A (en) * 1980-01-10 1983-06-14 Rohm Gmbh Rapid diagnostic agents
DE2950501C1 (en) * 1978-05-17 1983-07-07 Battelle Memorial Institute, 1227 Carouge, Genève Test strip fan
EP0110173A1 (en) 1982-11-01 1984-06-13 Lifescan, Inc. Test device and method for in a colored aqueous fluid by diffuse reflectance detecting a soluble analyte measurement
US4543338A (en) * 1983-06-03 1985-09-24 Miles Laboratories, Inc. Wipe-off test device
US4582811A (en) * 1983-02-02 1986-04-15 Australian Monoclonal Development Pty. Ltd. Method and diagnostic aid for detecting occult faecal blood
US4587099A (en) * 1981-05-09 1986-05-06 Boehringer Mannheim Gmbh Test strips for the detection of a liquid sample component
US4621049A (en) * 1984-11-19 1986-11-04 Miles Laboratories, Inc. Enzymatic high range glucose test
US4645744A (en) * 1983-05-12 1987-02-24 Miles Laboratories, Inc. Unified test means for ion determination
US4670218A (en) * 1984-02-24 1987-06-02 Miles Laboratories, Inc. Ion test means having a porous carrier matrix
US4734375A (en) * 1980-05-27 1988-03-29 Miles Laboratories, Inc. Ion specific test method
WO1988005912A1 (en) * 1987-01-28 1988-08-11 Technimed Corporation Dry reagent delivery system
US4780411A (en) * 1984-09-22 1988-10-25 Bayer Aktiengesellschaft Water-absorbing, essentially water-free membrane for reagent substrates and methods of preparing the same
US4803158A (en) * 1983-03-08 1989-02-07 Kabushiki Kaisha Kyoto Daiichi Kagaku Composition used for the determination of beta-hydroxybutyric acid and a method for preparing the said composition
US4810633A (en) * 1984-06-04 1989-03-07 Miles Inc. Enzymatic ethanol test
US4816224A (en) * 1980-08-05 1989-03-28 Boehringer Mannheim Gmbh Device for separating plasma or serum from whole blood and analyzing the same
US4820489A (en) * 1982-12-23 1989-04-11 Boehringer Mannheim Gmbh Test strips and a process for the production thereof
US4883764A (en) * 1987-07-20 1989-11-28 Kloepfer Mary A Blood test strip
US4895704A (en) * 1985-04-23 1990-01-23 Fuji Photo Film Co., Ltd. Integral multilayer analytical element
EP0371513A2 (en) 1988-12-01 1990-06-06 Kyoto Daiichi Kagaku Co., Ltd. Device and method for assay of liquid sample
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US4935347A (en) * 1976-01-12 1990-06-19 Radiometer Corporate Development Ltd. Stabilization of compounds
US4956300A (en) * 1982-01-05 1990-09-11 Helena Laboratories Corporation Aid for determining the presence of occult blood, method of making the aid, and method of using the aid
US4966855A (en) * 1984-07-07 1990-10-30 Boehringer Mannheim Gmbh New redox indicators
US4994238A (en) * 1988-06-09 1991-02-19 Daffern George M Constant volume chemical analysis test device
US5055195A (en) * 1983-07-02 1991-10-08 Boehringer Mannheim Gmbh Erythrocyte-retention substrates
US5081040A (en) * 1987-06-29 1992-01-14 Helena Laboratories Corporation Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes
US5106581A (en) * 1991-05-30 1992-04-21 Industrial Test Systems, Inc. Test device for detection of molybdate, vanadate and ferric ions
US5106757A (en) * 1989-02-25 1992-04-21 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Process for the visualization of substance stains on layer chromatograms
US5186843A (en) * 1991-07-22 1993-02-16 Ahlstrom Filtration, Inc. Blood separation media and method for separating plasma from whole blood
US5196167A (en) * 1989-04-04 1993-03-23 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5273888A (en) * 1984-01-16 1993-12-28 Helena Laboratories Corporation Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals
US5304467A (en) * 1988-11-30 1994-04-19 Kyoto Daiichi Kagaku Co., Ltd. Device for assay of liquid sample
US5536470A (en) * 1991-02-28 1996-07-16 Boehringer Mannheim Gmbh Test carrier for determining an analyte in whole blood
US5660798A (en) * 1993-04-20 1997-08-26 Actimed Laboratories, Inc. Apparatus for red blood cell separation
US5681529A (en) * 1994-08-25 1997-10-28 Nihon Medi-Physics Co., Ltd. Biological fluid analyzing device
US5702913A (en) * 1983-12-21 1997-12-30 Helena Laboratories Corporation Chromgen-reagent test system
US5766552A (en) * 1993-04-20 1998-06-16 Actimed Laboratories, Inc. Apparatus for red blood cell separation
US5962215A (en) * 1996-04-05 1999-10-05 Mercury Diagnostics, Inc. Methods for testing the concentration of an analyte in a body fluid
US6036919A (en) * 1996-07-23 2000-03-14 Roche Diagnostic Gmbh Diagnostic test carrier with multilayer field
US6069011A (en) * 1997-12-10 2000-05-30 Umm Electronics, Inc. Method for determining the application of a sample fluid on an analyte strip using first and second derivatives
US6162397A (en) * 1998-08-13 2000-12-19 Lifescan, Inc. Visual blood glucose test strip
DE19826957C2 (en) * 1997-06-17 2001-11-08 Mercury Diagnostics Inc Device for determining an analyte in a body fluid
US6458326B1 (en) 1999-11-24 2002-10-01 Home Diagnostics, Inc. Protective test strip platform
US20030003522A1 (en) * 2001-06-29 2003-01-02 International Business Machines Corporation Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements
US6525330B2 (en) 2001-02-28 2003-02-25 Home Diagnostics, Inc. Method of strip insertion detection
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
US20030098661A1 (en) * 2001-11-29 2003-05-29 Ken Stewart-Smith Control system for vehicle seats
US6635439B2 (en) 2000-12-21 2003-10-21 Ethicon, Inc. Hydrogen peroxide indicator employing enzyme and dye
US20040074768A1 (en) * 2002-10-18 2004-04-22 Anex Deon S. Electrokinetic pump having capacitive electrodes
US20040116829A1 (en) * 2001-06-08 2004-06-17 Raney Charles C. Sampling devices and methods utilizing a horizontal capillary test strip
US20040191119A1 (en) * 2003-03-24 2004-09-30 Zanzucchi Peter J. Analyte concentration detection devices and methods
US20050039747A1 (en) * 2001-09-24 2005-02-24 Fukunaga Atsuo F. Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilization of fresh gases
US20050230080A1 (en) * 2004-04-19 2005-10-20 Paul Phillip H Electrokinetic pump driven heat transfer system
US20050247558A1 (en) * 2002-07-17 2005-11-10 Anex Deon S Electrokinetic delivery systems, devices and methods
US7049130B2 (en) 1997-06-10 2006-05-23 Home Diagnostics, Inc. Diagnostic sanitary test strip
US20060281187A1 (en) * 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US20070274861A1 (en) * 2004-12-07 2007-11-29 Roche Diagnostics Operations, Inc. Membranes and methods for coating membranes
US20090123955A1 (en) * 2004-12-13 2009-05-14 Bayer Healthcare Llc Size Self-Limiting Compositions and Test Devices for Measuring Analytes in Biological Fluids
US20100028920A1 (en) * 2007-03-05 2010-02-04 Advanced Liquid Logic, Inc. Hydrogen Peroxide Droplet-Based Assays
US7867592B2 (en) 2007-01-30 2011-01-11 Eksigent Technologies, Inc. Methods, compositions and devices, including electroosmotic pumps, comprising coated porous surfaces
US20110168645A1 (en) * 2004-08-05 2011-07-14 Akers Biosciences, Inc. Method for preparing a fluid fraction from blood
US8152477B2 (en) 2005-11-23 2012-04-10 Eksigent Technologies, Llc Electrokinetic pump designs and drug delivery systems
US8251672B2 (en) 2007-12-11 2012-08-28 Eksigent Technologies, Llc Electrokinetic pump with fixed stroke volume
US8360993B2 (en) 2005-09-30 2013-01-29 Intuity Medical, Inc. Method for body fluid sample extraction
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US8979511B2 (en) 2011-05-05 2015-03-17 Eksigent Technologies, Llc Gel coupling diaphragm for electrokinetic delivery systems
US9089293B2 (en) 2009-08-13 2015-07-28 Roche Diabetes Care, Inc. Test element for analyzing a body fluid
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US9664668B2 (en) 2012-05-03 2017-05-30 Qualigen, Inc. Whole blood analytic device and method therefor
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
US10383556B2 (en) 2008-06-06 2019-08-20 Intuity Medical, Inc. Medical diagnostic devices and methods
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5592698A (en) * 1978-12-31 1980-07-14 Kyoto Daiichi Kagaku:Kk Test strip for glucose determination
GB2120787B (en) * 1982-05-26 1986-02-19 Lilly Industries Ltd Method of estimating feed additives
US4689309A (en) * 1985-09-30 1987-08-25 Miles Laboratories, Inc. Test device, method of manufacturing same and method of determining a component in a sample
DE19834938C2 (en) * 1998-07-29 2000-07-20 Coty Bv Method for the cosmetic tanning determination of a self-tanning composition and test kit
US6696240B1 (en) 1999-10-26 2004-02-24 Micronix, Inc. Capillary test strip to separate particulates
DE102004024432A1 (en) * 2004-05-14 2005-12-08 Tesa Ag Use of a hydrophilic surface film in medical diagnostic strips
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid

Cited By (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897214A (en) * 1971-11-24 1975-07-29 Boehringer Mannheim Gmbh Diagnostic device
US3975162A (en) * 1974-03-13 1976-08-17 Marine Colloids, Inc. Applying reagent to medium and device therefor
USRE30267E (en) * 1975-06-20 1980-05-06 Eastman Kodak Company Multilayer analytical element
US4066403A (en) * 1975-06-20 1978-01-03 Eastman Kodak Company Multilayer analytical element
US4020006A (en) * 1975-08-14 1977-04-26 Icl/Scientific Fluid containing dispersed particles simulating leukocytes and method for producing same
US4935347A (en) * 1976-01-12 1990-06-19 Radiometer Corporate Development Ltd. Stabilization of compounds
DE2614192A1 (en) * 1976-04-02 1977-10-20 Marine Colloids Inc ANALYZING DEVICE AND ANALYZING METHOD
US4283491A (en) * 1977-09-06 1981-08-11 Eastman Kodak Company Analytical elements with improved reagent stability
DE2950501C1 (en) * 1978-05-17 1983-07-07 Battelle Memorial Institute, 1227 Carouge, Genève Test strip fan
US4175923A (en) * 1978-06-26 1979-11-27 Friend William G Method and apparatus for occult blood testing in the home
US4298498A (en) * 1978-12-21 1981-11-03 Boehringer Mannheim Gmbh Control reagent for test strips for determining urobilinogen in urine
US4312834A (en) * 1979-03-15 1982-01-26 Boehringer Mannheim Gmbh Diagnostic agent for the detection of component materials in liquid and process for producing same
US4388271A (en) * 1980-01-10 1983-06-14 Rohm Gmbh Rapid diagnostic agents
US4303753A (en) * 1980-03-20 1981-12-01 Miles Laboratories, Inc. Method and device for the semiquantitative determination of glucose in aqueous fluids
US4734375A (en) * 1980-05-27 1988-03-29 Miles Laboratories, Inc. Ion specific test method
US4816224A (en) * 1980-08-05 1989-03-28 Boehringer Mannheim Gmbh Device for separating plasma or serum from whole blood and analyzing the same
US4318985A (en) * 1981-01-29 1982-03-09 Miles Laboratories, Inc. Method and device for detecting glucose concentration
US4587099A (en) * 1981-05-09 1986-05-06 Boehringer Mannheim Gmbh Test strips for the detection of a liquid sample component
US4956300A (en) * 1982-01-05 1990-09-11 Helena Laboratories Corporation Aid for determining the presence of occult blood, method of making the aid, and method of using the aid
EP0110173A1 (en) 1982-11-01 1984-06-13 Lifescan, Inc. Test device and method for in a colored aqueous fluid by diffuse reflectance detecting a soluble analyte measurement
US4820489A (en) * 1982-12-23 1989-04-11 Boehringer Mannheim Gmbh Test strips and a process for the production thereof
US4582811A (en) * 1983-02-02 1986-04-15 Australian Monoclonal Development Pty. Ltd. Method and diagnostic aid for detecting occult faecal blood
US4803158A (en) * 1983-03-08 1989-02-07 Kabushiki Kaisha Kyoto Daiichi Kagaku Composition used for the determination of beta-hydroxybutyric acid and a method for preparing the said composition
US4645744A (en) * 1983-05-12 1987-02-24 Miles Laboratories, Inc. Unified test means for ion determination
US4543338A (en) * 1983-06-03 1985-09-24 Miles Laboratories, Inc. Wipe-off test device
US5055195A (en) * 1983-07-02 1991-10-08 Boehringer Mannheim Gmbh Erythrocyte-retention substrates
US5702913A (en) * 1983-12-21 1997-12-30 Helena Laboratories Corporation Chromgen-reagent test system
US5273888A (en) * 1984-01-16 1993-12-28 Helena Laboratories Corporation Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals
US4670218A (en) * 1984-02-24 1987-06-02 Miles Laboratories, Inc. Ion test means having a porous carrier matrix
US4810633A (en) * 1984-06-04 1989-03-07 Miles Inc. Enzymatic ethanol test
US4966855A (en) * 1984-07-07 1990-10-30 Boehringer Mannheim Gmbh New redox indicators
US4780411A (en) * 1984-09-22 1988-10-25 Bayer Aktiengesellschaft Water-absorbing, essentially water-free membrane for reagent substrates and methods of preparing the same
US4621049A (en) * 1984-11-19 1986-11-04 Miles Laboratories, Inc. Enzymatic high range glucose test
US4895704A (en) * 1985-04-23 1990-01-23 Fuji Photo Film Co., Ltd. Integral multilayer analytical element
US6858401B2 (en) 1986-08-13 2005-02-22 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5843692A (en) * 1986-08-13 1998-12-01 Lifescan, Inc. Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood
US6268162B1 (en) 1986-08-13 2001-07-31 Lifescan, Inc. Reflectance measurement of analyte concentration with automatic initiation of timing
SG83640A1 (en) * 1986-08-13 2001-10-16 Lifescan Inc Method of operation of reflectance-reading devices
US5304468A (en) * 1986-08-13 1994-04-19 Lifescan, Inc. Reagent test strip and apparatus for determination of blood glucose
US6821483B2 (en) 1986-08-13 2004-11-23 Lifescan, Inc. Reagents test strip with alignment notch
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5179005A (en) * 1986-08-13 1993-01-12 Lifescan, Inc. Minimum procedure system for the determination of analytes
US6881550B2 (en) 1986-08-13 2005-04-19 Roger Phillips Method for the determination of glucose employing an apparatus emplaced matrix
US6887426B2 (en) 1986-08-13 2005-05-03 Roger Phillips Reagents test strip adapted for receiving an unmeasured sample while in use in an apparatus
US5563042A (en) * 1986-08-13 1996-10-08 Lifescan, Inc. Whole blood glucose test strip
CN1036867C (en) * 1986-08-13 1997-12-31 生命扫描有限公司 Minimum procedure system for determination of analytes
WO1988005912A1 (en) * 1987-01-28 1988-08-11 Technimed Corporation Dry reagent delivery system
US4774192A (en) * 1987-01-28 1988-09-27 Technimed Corporation A dry reagent delivery system with membrane having porosity gradient
US5081040A (en) * 1987-06-29 1992-01-14 Helena Laboratories Corporation Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes
US4883764A (en) * 1987-07-20 1989-11-28 Kloepfer Mary A Blood test strip
US4994238A (en) * 1988-06-09 1991-02-19 Daffern George M Constant volume chemical analysis test device
US5304467A (en) * 1988-11-30 1994-04-19 Kyoto Daiichi Kagaku Co., Ltd. Device for assay of liquid sample
EP0371513A2 (en) 1988-12-01 1990-06-06 Kyoto Daiichi Kagaku Co., Ltd. Device and method for assay of liquid sample
US5106757A (en) * 1989-02-25 1992-04-21 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Process for the visualization of substance stains on layer chromatograms
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5196167A (en) * 1989-04-04 1993-03-23 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5536470A (en) * 1991-02-28 1996-07-16 Boehringer Mannheim Gmbh Test carrier for determining an analyte in whole blood
US5106581A (en) * 1991-05-30 1992-04-21 Industrial Test Systems, Inc. Test device for detection of molybdate, vanadate and ferric ions
US5186843A (en) * 1991-07-22 1993-02-16 Ahlstrom Filtration, Inc. Blood separation media and method for separating plasma from whole blood
US5660798A (en) * 1993-04-20 1997-08-26 Actimed Laboratories, Inc. Apparatus for red blood cell separation
US5766552A (en) * 1993-04-20 1998-06-16 Actimed Laboratories, Inc. Apparatus for red blood cell separation
US5681529A (en) * 1994-08-25 1997-10-28 Nihon Medi-Physics Co., Ltd. Biological fluid analyzing device
US6818180B2 (en) 1996-04-05 2004-11-16 Roche Diagnostics Operations, Inc. Devices for testing for the presence and/or concentration of an analyte in a body fluid
US5962215A (en) * 1996-04-05 1999-10-05 Mercury Diagnostics, Inc. Methods for testing the concentration of an analyte in a body fluid
US6036919A (en) * 1996-07-23 2000-03-14 Roche Diagnostic Gmbh Diagnostic test carrier with multilayer field
US20070048878A1 (en) * 1997-06-10 2007-03-01 Home Diagnostics, Inc. Diagnostic sanitary test strip
US7049130B2 (en) 1997-06-10 2006-05-23 Home Diagnostics, Inc. Diagnostic sanitary test strip
US7560288B2 (en) 1997-06-10 2009-07-14 Home Diagnostics, Inc. Diagnostic sanitary test strip
DE19826957C2 (en) * 1997-06-17 2001-11-08 Mercury Diagnostics Inc Device for determining an analyte in a body fluid
US6069011A (en) * 1997-12-10 2000-05-30 Umm Electronics, Inc. Method for determining the application of a sample fluid on an analyte strip using first and second derivatives
US6162397A (en) * 1998-08-13 2000-12-19 Lifescan, Inc. Visual blood glucose test strip
US6979571B2 (en) 1999-11-24 2005-12-27 Home Diagnostics, Inc. Method of using a protective test strip platform for optical meter apparatus
US6458326B1 (en) 1999-11-24 2002-10-01 Home Diagnostics, Inc. Protective test strip platform
US6635439B2 (en) 2000-12-21 2003-10-21 Ethicon, Inc. Hydrogen peroxide indicator employing enzyme and dye
US6525330B2 (en) 2001-02-28 2003-02-25 Home Diagnostics, Inc. Method of strip insertion detection
US7390665B2 (en) 2001-02-28 2008-06-24 Gilmour Steven B Distinguishing test types through spectral analysis
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
US20040116829A1 (en) * 2001-06-08 2004-06-17 Raney Charles C. Sampling devices and methods utilizing a horizontal capillary test strip
US7476202B2 (en) 2001-06-08 2009-01-13 Roche Diagnostics Operations, Inc. Sampling devices and methods utilizing a horizontal capillary test strip
US6844149B2 (en) 2001-06-29 2005-01-18 International Business Machines Corporation Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements
US20030003522A1 (en) * 2001-06-29 2003-01-02 International Business Machines Corporation Method, system, and apparatus for measurement and recording of blood chemistry and other physiological measurements
US20050039747A1 (en) * 2001-09-24 2005-02-24 Fukunaga Atsuo F. Breathing circuits having unconventional respiratory conduits and systems and methods for optimizing utilization of fresh gases
US20030098661A1 (en) * 2001-11-29 2003-05-29 Ken Stewart-Smith Control system for vehicle seats
US10772550B2 (en) 2002-02-08 2020-09-15 Intuity Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US7517440B2 (en) 2002-07-17 2009-04-14 Eksigent Technologies Llc Electrokinetic delivery systems, devices and methods
US20050247558A1 (en) * 2002-07-17 2005-11-10 Anex Deon S Electrokinetic delivery systems, devices and methods
US7267753B2 (en) 2002-10-18 2007-09-11 Eksigent Technologies Llc Electrokinetic device having capacitive electrodes
US20040074784A1 (en) * 2002-10-18 2004-04-22 Anex Deon S. Electrokinetic device having capacitive electrodes
US7235164B2 (en) 2002-10-18 2007-06-26 Eksigent Technologies, Llc Electrokinetic pump having capacitive electrodes
US7875159B2 (en) 2002-10-18 2011-01-25 Eksigent Technologies, Llc Electrokinetic pump having capacitive electrodes
US8192604B2 (en) 2002-10-18 2012-06-05 Eksigent Technologies, Llc Electrokinetic pump having capacitive electrodes
US20040074768A1 (en) * 2002-10-18 2004-04-22 Anex Deon S. Electrokinetic pump having capacitive electrodes
US8715480B2 (en) 2002-10-18 2014-05-06 Eksigent Technologies, Llc Electrokinetic pump having capacitive electrodes
US9095292B2 (en) 2003-03-24 2015-08-04 Intuity Medical, Inc. Analyte concentration detection devices and methods
US20040191119A1 (en) * 2003-03-24 2004-09-30 Zanzucchi Peter J. Analyte concentration detection devices and methods
US7427377B2 (en) 2003-03-24 2008-09-23 Intuity Medical, Inc. Analyte concentration detection devices and methods
US20050202567A1 (en) * 2003-03-24 2005-09-15 Zanzucchi Peter J. Analyte concentration detection devices and methods
US8231832B2 (en) 2003-03-24 2012-07-31 Intuity Medical, Inc. Analyte concentration detection devices and methods
US7052652B2 (en) 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US7559356B2 (en) 2004-04-19 2009-07-14 Eksident Technologies, Inc. Electrokinetic pump driven heat transfer system
US20050230080A1 (en) * 2004-04-19 2005-10-20 Paul Phillip H Electrokinetic pump driven heat transfer system
US8097171B2 (en) 2004-08-05 2012-01-17 Akers Biosciences, Inc. Method of separating a fluid fraction from whole blood
US20110168645A1 (en) * 2004-08-05 2011-07-14 Akers Biosciences, Inc. Method for preparing a fluid fraction from blood
US8202490B2 (en) 2004-12-07 2012-06-19 Roche Diagnostics Operations, Inc. Membranes and methods for coating membranes
US20110194980A1 (en) * 2004-12-07 2011-08-11 Roche Diagnostics Operations, Inc. Process For Hydrophilizing Surfaces Of Fluidic Components And Systems
US7955563B2 (en) 2004-12-07 2011-06-07 Roche Diagnostics Operations, Inc. Methods for applying reactive films containing solids to microporous membranes and membranes produced therefrom
US20070274861A1 (en) * 2004-12-07 2007-11-29 Roche Diagnostics Operations, Inc. Membranes and methods for coating membranes
US20090123955A1 (en) * 2004-12-13 2009-05-14 Bayer Healthcare Llc Size Self-Limiting Compositions and Test Devices for Measuring Analytes in Biological Fluids
US7964372B2 (en) 2004-12-13 2011-06-21 Bayer Healthcare Llc Size self-limiting compositions and test devices for measuring analytes in biological fluids
US9982289B2 (en) 2004-12-13 2018-05-29 Ascensia Diabetes Care Holdings Ag Size self-limiting compositions and test devices for measuring analytes in biological fluids
US11419532B2 (en) 2005-06-13 2022-08-23 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US20060281187A1 (en) * 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US10226208B2 (en) 2005-06-13 2019-03-12 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US9366636B2 (en) 2005-06-13 2016-06-14 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US8969097B2 (en) 2005-06-13 2015-03-03 Intuity Medical, Inc. Analyte detection devices and methods with hematocrit-volume correction and feedback control
US10441205B2 (en) 2005-09-30 2019-10-15 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US9839384B2 (en) 2005-09-30 2017-12-12 Intuity Medical, Inc. Body fluid sampling arrangements
US8795201B2 (en) 2005-09-30 2014-08-05 Intuity Medical, Inc. Catalysts for body fluid sample extraction
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US10842427B2 (en) 2005-09-30 2020-11-24 Intuity Medical, Inc. Body fluid sampling arrangements
US9060723B2 (en) 2005-09-30 2015-06-23 Intuity Medical, Inc. Body fluid sampling arrangements
US10433780B2 (en) 2005-09-30 2019-10-08 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US8382681B2 (en) 2005-09-30 2013-02-26 Intuity Medical, Inc. Fully integrated wearable or handheld monitor
US8360994B2 (en) 2005-09-30 2013-01-29 Intuity Medical, Inc. Arrangement for body fluid sample extraction
US9380974B2 (en) 2005-09-30 2016-07-05 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US8360993B2 (en) 2005-09-30 2013-01-29 Intuity Medical, Inc. Method for body fluid sample extraction
US8152477B2 (en) 2005-11-23 2012-04-10 Eksigent Technologies, Llc Electrokinetic pump designs and drug delivery systems
US8794929B2 (en) 2005-11-23 2014-08-05 Eksigent Technologies Llc Electrokinetic pump designs and drug delivery systems
US7867592B2 (en) 2007-01-30 2011-01-11 Eksigent Technologies, Inc. Methods, compositions and devices, including electroosmotic pumps, comprising coated porous surfaces
US8426213B2 (en) * 2007-03-05 2013-04-23 Advanced Liquid Logic Inc Hydrogen peroxide droplet-based assays
US20100028920A1 (en) * 2007-03-05 2010-02-04 Advanced Liquid Logic, Inc. Hydrogen Peroxide Droplet-Based Assays
US8251672B2 (en) 2007-12-11 2012-08-28 Eksigent Technologies, Llc Electrokinetic pump with fixed stroke volume
US9833183B2 (en) 2008-05-30 2017-12-05 Intuity Medical, Inc. Body fluid sampling device—sampling site interface
US11045125B2 (en) 2008-05-30 2021-06-29 Intuity Medical, Inc. Body fluid sampling device-sampling site interface
US11553860B2 (en) 2008-06-06 2023-01-17 Intuity Medical, Inc. Medical diagnostic devices and methods
US11399744B2 (en) 2008-06-06 2022-08-02 Intuity Medical, Inc. Detection meter and mode of operation
US9636051B2 (en) 2008-06-06 2017-05-02 Intuity Medical, Inc. Detection meter and mode of operation
US10383556B2 (en) 2008-06-06 2019-08-20 Intuity Medical, Inc. Medical diagnostic devices and methods
US9089293B2 (en) 2009-08-13 2015-07-28 Roche Diabetes Care, Inc. Test element for analyzing a body fluid
US9897610B2 (en) 2009-11-30 2018-02-20 Intuity Medical, Inc. Calibration material delivery devices and methods
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US11002743B2 (en) 2009-11-30 2021-05-11 Intuity Medical, Inc. Calibration material delivery devices and methods
US10330667B2 (en) 2010-06-25 2019-06-25 Intuity Medical, Inc. Analyte monitoring methods and systems
US8979511B2 (en) 2011-05-05 2015-03-17 Eksigent Technologies, Llc Gel coupling diaphragm for electrokinetic delivery systems
US11051734B2 (en) 2011-08-03 2021-07-06 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11382544B2 (en) 2011-08-03 2022-07-12 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9782114B2 (en) 2011-08-03 2017-10-10 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US11672452B2 (en) 2011-08-03 2023-06-13 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
US9664668B2 (en) 2012-05-03 2017-05-30 Qualigen, Inc. Whole blood analytic device and method therefor
US10729386B2 (en) 2013-06-21 2020-08-04 Intuity Medical, Inc. Analyte monitoring system with audible feedback

Also Published As

Publication number Publication date
FI48306C (en) 1974-08-12
DE1598153B2 (en) 1973-05-03
AT282832B (en) 1970-07-10
BR6794865D0 (en) 1973-03-20
GB1159627A (en) 1969-07-30
SE413439B (en) 1980-05-27
NL145048B (en) 1975-02-17
CY789A (en) 1976-06-01
JPS4933800B1 (en) 1974-09-10
GR38283B (en) 1969-10-17
NL6715828A (en) 1968-05-24
FI48306B (en) 1974-04-30
DE1598153C3 (en) 1973-11-22
CH480634A (en) 1969-10-31
DE1598153A1 (en) 1970-04-23

Similar Documents

Publication Publication Date Title
US3630957A (en) Diagnostic agent
US4312834A (en) Diagnostic agent for the detection of component materials in liquid and process for producing same
Davies et al. Polymer membranes in clinical sensor applications: I. An overview of membrane function
US3298789A (en) Test article for the detection of glucose
CA1219797A (en) Test strips
JP5912213B2 (en) Size self-regulating composition and test apparatus for measuring analytes in biological fluids
US3814668A (en) Method and device for the semi-quantitative determination of glucose in aqueous fluids
US3092465A (en) Diagnostic test device for blood sugar
US5128171A (en) Method of making a test strip having a dialyzed polymer layer
Adeloju et al. Polypyrrole-based potentiometric biosensor for urea part 1. Incorporation of urease
US3453180A (en) Test article
JPS60209174A (en) Test apparatus and method for detecting component of liquid sample
US4231754A (en) Chemiluminescent analytical device
GB2026160A (en) Test strip for determiation of glucose
JPS62119454A (en) Transparent test piece system
US5064615A (en) Method and reagent for determining the ionic strength of specific gravity of aqueous liquids
US3630847A (en) Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances
US3654180A (en) Indicator for detecting hydrogen peroxide and peroxidative compounds containing alpha naphthoflavone
AU633210B2 (en) Asymmetric sandwich membrane system as diagnostic test device
CS207346B2 (en) Chemical indication papers
US3427225A (en) Test composition,device and method for detecting urea in aqueous fluids
US3531254A (en) Test article and method for the detection of urea
Christie et al. Direct electrochemical determination of paracetamol in plasma
Capitán-Vallvey et al. Single-use optical sensor for the determination of iron in water and white wines
JPH08502348A (en) Sensor device